REG.AX

Regis Healthcare Limited
ASXAUDEQUITY Healthcare DELAYED
Last price
6.01
▼ 0.31 (4.91%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
6.16
Prev close
6.32
Day high
6.24
Day low
5.57
Volume
1.47M
Market cap
$1.82B
P/E (TTM)
33.39
52W range
5.57 – 9.40

Day trading desk

Current session · delayed
Gap from prior close
-2.53%
Prior close 6.32
VWAP
5.85
+2.76% from price
Relative volume
2.21×
Unusually busy
Session range
11.48%
5.53 – 6.16
Position in range
76%
Near session high
ATR (14D)
0.27
4.49% of price
Prior day high
6.86
PDH
Prior day low
6.28
PDL
Bid / ask spread
Quote not published
Session volume
1.43M
Avg 648.43K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-3.06% -1.9%
1M
-1.64% -5.0%
3M
-8.66% -11.1%
6M
-11.88% -23.8%
YTD
-13.53% -25.5%
1Y
-23.44% -43.6%
3Y
+139.44% +64.5%
5Y
+190.34%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on REG.AX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
119.74M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jun 19, 26
Mellors (Linda Jane)
Former
195.74K Direct
May 4, 26
Mellors (Linda Jane)
Chief Executive Officer
SELL 223.95K $1.07M Direct
Feb 25, 26
Monaghan (Carmel Anne)
Director (Non-Executive)
OTHER 2.20K $10.80K Direct
Oct 13, 25
Mellors (Linda Jane)
Chief Executive Officer
419.69K Direct
Sep 2, 25
Freeman (Sally Margaret)
Independent Non-Executive Director
BUY 47.66K $242.08K Direct
Aug 29, 25
Hodges (Graham Kennedy)
Independent Non-Executive Chairman
BUY 22.00K $111.55K Direct
Aug 27, 25
Leonard (Jodie Lee)
Independent Non-Executive Director
BUY 12.50K $64.23K Direct
Jun 30, 25
Freeman (Sally Margaret)
Independent Non-Executive Director
52.46K Direct
Jun 30, 25
Rostolis (Rick C.)
Chief Financial Officer
51.24K Direct
Nov 13, 24
Leonard (Jodie Lee)
Independent Non-Executive Director
BUY 7.69K $32.56K Direct
Sep 20, 24
Mellors (Linda Jane)
Chief Executive Officer
71.03K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

6 reporting
NameRelationShares heldLatest
Freeman (Sally Margaret)
Independent Non-Executive Director 87.27K Purchase
Hodges (Graham Kennedy)
Independent Non-Executive Chairman 132.00K Purchase
Leonard (Jodie Lee)
Independent Non-Executive Director 33.70K Purchase
Mellors (Linda Jane)
Former 284.27K Other
Monaghan (Carmel Anne)
Director (Non-Executive) 2.20K Other
Rostolis (Rick C.)
Chief Financial Officer 134.12K Other

Fundamentals

TTM · reported
Market cap$1.82B
Enterprise value$1.72B
Revenue (TTM)$1.26B
Gross profit$202.45M
EBITDA$113.17M
Net income$38.03M
EPS (TTM)$0.18
Free cash flow$403.05M
Total cash$197.97M
Total debt$4.75M
Book value / share$-0.10
Shares outstanding302.36M
Float182.61M
Short % of float
Dividend yield2.85%
Beta (5Y)0.82

Valuation & profitability ratios

Account required
Trailing P/E33.39
Forward P/E23.06
PEG ratio
Price / sales
Price / book
EV / revenue1.36
EV / EBITDA15.18
Gross margin16.01%
Operating margin5.54%
Profit margin3.01%
Return on equity
Return on assets1.68%
Debt / equity
Current ratio0.09
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 1 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $1.16B$1.01B$230.99M$207.47M +14.5%
Operating revenue $1.16B$1.01B$230.99M$207.47M +14.5%
Gross profit $1.16B$1.01B$230.99M$207.47M +14.5%
Selling, general & admin $978.97M$864.47M$680.32M$619.50M +13.2%
Total operating expense $1.10B$1.05B$864.39M$781.76M +4.4%
Operating income $60.03M-$40.89M-$633.40M-$574.28M +246.8%
Net interest income -$112.23M-$87.50M-$72.89M-$70.37M -28.3%
Pre-tax income $71.44M-$28.10M-$40.38M-$55.19M +354.2%
Tax provision $22.49M-$6.69M-$11.93M-$16.39M +436.2%
Net income $48.95M-$21.41M-$28.45M-$38.80M +328.6%
Net income to common $48.95M-$21.41M-$28.45M-$38.80M +328.6%
Basic EPS 0.16-0.07-0.09-0.13 +328.6%
Diluted EPS 0.16-0.07-0.09-0.13 +326.6%
EBIT $190.63M$63.17M$32.96M$14.86M +201.8%
EBITDA $240.44M$191.24M$159.42M$117.97M +25.7%
Basic shares 301.20M301.04M300.89M300.82M +0.1%
Diluted shares 303.85M301.04M300.89M300.82M +0.9%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year 0.23 6 $1.50B -2.6%
Next year 0.28 6 $1.60B +7.0%

Analyst targets & ownership

Account required
Mean target$7.69
High target$8.60
Low target$7.00
Implied upside28.00%
Analyst count7
ConsensusNONE
Strong buy / Buy1 / 3
Hold3
Sell / Strong sell0 / 0
Held by insiders39.60%
Held by institutions24.03%
Institutions holding55
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
6.21
-3.28% from price
SMA 20
6.24
-3.72% from price
SMA 50
6.28
-4.28% from price
SMA 100
6.27
-4.08% from price
SMA 200
6.59
-8.83% from price
EMA 12
6.23
-3.54% from price
EMA 26
6.23
-3.61% from price
EMA 50
6.25
-3.88% from price
RSI (14)
40.9
Neutral
MACD (12,26,9)
-0.00
Hist -0.00
ATR (14)
0.27
4.49% of price
Realised vol 30D
26.9%
Annualised
Bollinger upper
6.46
20, 2σ
Bollinger lower
6.02
20, 2σ
50 / 200 cross
Death
6.28 vs 6.59
Trend bias
Below 200
-8.83%

Options chain

Account required
Expiry
Spot 6.01
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.14
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
26.9%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-38.0%
Peak to trough
Max drawdown 5Y
-39.7%
Peak to trough
ATR 14
0.27
4.49% of price
Beta (reported)
0.82
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate$0.18 / yr
Forward yield2.85%
5-year avg yield2.77%
Payout ratio130.18%
Ex-dividend dateMar 12, 2026
Next pay date
Last split
Split date

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.